Skip to main content

Articles

93 result(s) for 'Me- cfs' within Journal of Translational Medicine

Page 1 of 2

  1. An amendment to this paper has been published and can be accessed via the original article.

    Authors:
    Citation: Journal of Translational Medicine 2021 19:217

    The original article was published in Journal of Translational Medicine 2021 19:50

  2. Lightheadedness, fatigue, weakness, heart palpitations, cognitive dysfunction, muscle pain, and exercise intolerance are some of the symptoms of orthostatic intolerance (OI). There is substantial comorbidity o...

    Authors: Jihyun Lee, Suzanne D. Vernon, Patricia Jeys, Weam Ali, Andrea Campos, Derya Unutmaz, Brayden Yellman and Lucinda Bateman
    Citation: Journal of Translational Medicine 2020 18:314
  3. Authors: L. D. Crosby, S. Kalanidhi, A. Bonilla, A. Subramanian, J. S. Ballon and H. Bonilla
    Citation: Journal of Translational Medicine 2021 19:50

    The Correction to this article has been published in Journal of Translational Medicine 2021 19:217

  4. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a complex and debilitating disease accompanied by muscular fatigue and pain. A functional measure to assess muscle fatigability of ME/CFS patients...

    Authors: Bianka Jäkel, Claudia Kedor, Patricia Grabowski, Kirsten Wittke, Silvia Thiel, Nadja Scherbakov, Wolfram Doehner, Carmen Scheibenbogen and Helma Freitag
    Citation: Journal of Translational Medicine 2021 19:159
  5. Chronic Fatigue Syndrome or Myalgic Encephaloymelitis (ME/CFS) is a frequent debilitating disease with an enigmatic etiology. The finding of autoantibodies against ß2-adrenergic receptors (ß2AdR) prompted us t...

    Authors: Klaus J. Wirth and Carmen Scheibenbogen
    Citation: Journal of Translational Medicine 2021 19:162
  6. There is no approved pharmaceutical intervention for Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (ME/CFS). Fatigue in these patients can last for decades. Long COVID may continue to ME/CFS, and current...

    Authors: Alan Cash and David Lyons Kaufman
    Citation: Journal of Translational Medicine 2022 20:295
  7. Since the 1990s, neuroimaging has been utilised to study Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), a debilitating illness with unknown aetiology. While brain abnormalities in ME/CFS have bee...

    Authors: Zack Y. Shan, Leighton R. Barnden, Richard A. Kwiatek, Sandeep Bhuta, Daniel F. Hermens and Jim Lagopoulos
    Citation: Journal of Translational Medicine 2020 18:335
  8. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex illness which disproportionally affects females. This illness is associated with immune and metabolic perturbations that may be influenc...

    Authors: Aurore Nkiliza, Megan Parks, Adam Cseresznye, Sarah Oberlin, James E. Evans, Teresa Darcey, Kristina Aenlle, Daniel Niedospial, Michael Mullan, Fiona Crawford, Nancy Klimas and Laila Abdullah
    Citation: Journal of Translational Medicine 2021 19:370
  9. Since the first 'ME' case definition was developed in 1986, 25 case definitions/diagnostic criteria were created based on three conceptual factors (etiology, pathophysiology, and exclusionary disorders). These fa...

    Authors: Eun-Jin Lim and Chang-Gue Son
    Citation: Journal of Translational Medicine 2020 18:289

    The Letter to the Editor to this article has been published in Journal of Translational Medicine 2020 18:447

  10. Chronic Fatigue Syndrome/Myalgic Encephalomyelitis/Systemic Exertion Intolerance Disease (CFS/ME/SEID) is a complex illness that has an unknown aetiology. It has been proposed that metabolomics may contribute ...

    Authors: Teilah Kathryn Huth, Natalie Eaton-Fitch, Donald Staines and Sonya Marshall-Gradisnik
    Citation: Journal of Translational Medicine 2020 18:198
  11. Orthostatic intolerance (OI) is a frequent finding in individuals with myalgic encephalomyelitis /chronic fatigue syndrome (ME/CFS). Published studies have proposed that deconditioning is an important pathophy...

    Authors: C. (Linda) M. C. van Campen, Peter C. Rowe and Frans C. Visser
    Citation: Journal of Translational Medicine 2021 19:193
  12. Earlier this year, we described an analysis of mitochondrial DNA (mtDNA) variants in myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS) patients and healthy controls. We reported that there was no s...

    Authors: Maureen R. Hanson, Zhenglong Gu, Alon Keinan, Kaixiong Ye, Arnaud Germain and Paul Billing-Ross
    Citation: Journal of Translational Medicine 2016 14:342
  13. Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is understood as a complex condition, likely triggered and sustained by an interplay of biological, psychological, and social factors. Little oversig...

    Authors: Ashley Elizabeth Muller, Kari Tveito, Inger Johanne Bakken, Signe A. Flottorp, Siri Mjaaland and Lillebeth Larun
    Citation: Journal of Translational Medicine 2020 18:484
  14. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Do-Young Kim, Jin-Seok Lee, Samuel-Young Park, Soo-Jin Kim and Chang-Gue Son
    Citation: Journal of Translational Medicine 2020 18:492

    The original article was published in Journal of Translational Medicine 2020 18:7

  15. Although medical requirements are urgent, no effective intervention has been proven for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). To facilitate the development of new therapeutics, we system...

    Authors: Do-Young Kim, Jin-Seok Lee, Samuel-Young Park, Soo-Jin Kim and Chang-Gue Son
    Citation: Journal of Translational Medicine 2020 18:7

    The Correction to this article has been published in Journal of Translational Medicine 2020 18:492

  16. Fatigue, exertion intolerance and post-exertional malaise are among the most frequent symptoms of Post-COVID Syndrome (PCS), with a subset of patients fulfilling criteria for Myalgic Encephalomyelitis/Chronic ...

    Authors: Milan Haffke, Helma Freitag, Gordon Rudolf, Martina Seifert, Wolfram Doehner, Nadja Scherbakov, Leif Hanitsch, Kirsten Wittke, Sandra Bauer, Frank Konietschke, Friedemann Paul, Judith Bellmann-Strobl, Claudia Kedor, Carmen Scheibenbogen and Franziska Sotzny
    Citation: Journal of Translational Medicine 2022 20:138
  17. Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) has been emerging as a significant health issue worldwide. This study aimed to systemically assess the prevalence of CFS/ME in various aspects of analys...

    Authors: Eun-Jin Lim, Yo-Chan Ahn, Eun-Su Jang, Si-Woo Lee, Su-Hwa Lee and Chang-Gue Son
    Citation: Journal of Translational Medicine 2020 18:100
  18. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is clinically defined and characterised by persistent disabling tiredness and exertional malaise, leading to functional impairment.

    Authors: Alice M. Richardson, Don P. Lewis, Badia Kita, Helen Ludlow, Nigel P. Groome, Mark P. Hedger, David M. de Kretser and Brett A. Lidbury
    Citation: Journal of Translational Medicine 2018 16:97
  19. Investigations of activin family proteins as serum biomarkers for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). CFS/ME is a disease with complex, wide-ranging symptoms, featuring persistent fati...

    Authors: Brett A. Lidbury, Badia Kita, Donald P. Lewis, Susan Hayward, Helen Ludlow, Mark P. Hedger and David M. de Kretser
    Citation: Journal of Translational Medicine 2017 15:60
  20. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex and controversial clinical condition without having established causative factors. Increasing numbers of cases during past decade have c...

    Authors: Santa Rasa, Zaiga Nora-Krukle, Nina Henning, Eva Eliassen, Evelina Shikova, Thomas Harrer, Carmen Scheibenbogen, Modra Murovska and Bhupesh K. Prusty
    Citation: Journal of Translational Medicine 2018 16:268
  21. Myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS) is a common and severe disease with a considerable social and economic impact. So far, the etiology is not known, and neither a diagnostic marker ...

    Authors: Carmen Scheibenbogen, Helma Freitag, Julià Blanco, Enrica Capelli, Eliana Lacerda, Jerome Authier, Mira Meeus, Jesus Castro Marrero, Zaiga Nora-Krukle, Elisa Oltra, Elin Bolle Strand, Evelina Shikova, Slobodan Sekulic and Modra Murovska
    Citation: Journal of Translational Medicine 2017 15:162
  22. Research has identified immunological abnormalities in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME), a heterogeneous illness with an unknown cause and absence of diagnostic test. There have been...

    Authors: Sharni Lee Hardcastle, Ekua Weba Brenu, Samantha Johnston, Thao Nguyen, Teilah Huth, Sandra Ramos, Donald Staines and Sonya Marshall-Gradisnik
    Citation: Journal of Translational Medicine 2015 13:299
  23. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a serious and complex physical illness that affects all body systems with a multiplicity of symptoms, but key hallmarks of the disease are pervasi...

    Authors: Eiren Sweetman, Torsten Kleffmann, Christina Edgar, Michel de Lange, Rosamund Vallings and Warren Tate
    Citation: Journal of Translational Medicine 2020 18:365
  24. Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) or Systemic Exertion Intolerance Disease (SEID) present with a constellation of symptoms including debilitating fatigue that is unrelie...

    Authors: Sean Holden, Rebekah Maksoud, Natalie Eaton-Fitch, Hélène Cabanas, Donald Staines and Sonya Marshall-Gradisnik
    Citation: Journal of Translational Medicine 2020 18:290

    The Correction to this article has been published in Journal of Translational Medicine 2020 18:407

  25. Chronic fatigue syndrome (CFS) is a heterogeneous disorder with uncertain pathogenesis. Without effective therapy, CFS is characterized by disabling fatigue, depression, memory loss, and somatic discomfort. Th...

    Authors: Tiansong Yang, Yan Yang, Delong Wang, Chaoran Li, Yuanyuan Qu, Jing Guo, Tianyu Shi, Wang Bo, Zhongren Sun and Tetsuya Asakawa
    Citation: Journal of Translational Medicine 2019 17:213
  26. Due to the inconsistent use of diagnostic criteria in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), it is unsure whether physiotherapeutic management regarded effective in ME/CFS is appropriate ...

    Authors: Marjon E. A. Wormgoor and Sanne C. Rodenburg
    Citation: Journal of Translational Medicine 2021 19:1
  27. The pursuit for clarity in diagnostic and treatment pathways for the complex, chronic condition of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) continues. This systematic review raises a novel q...

    Authors: Amy Wallis, Michelle Ball, Sandra McKechnie, Henry Butt, Donald P. Lewis and Dorothy Bruck
    Citation: Journal of Translational Medicine 2017 15:129
  28. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a debilitating disease of unknown etiology lasting for a minimum of 6 months but usually for many years, with features including fatigue, cognitiv...

    Authors: Ludovic Giloteaux, Adam O’Neal, Jesús Castro-Marrero, Susan M. Levine and Maureen R. Hanson
    Citation: Journal of Translational Medicine 2020 18:387
  29. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a serious disorder of unknown aetiology. While the pathomechanism of ME/CFS remains elusive, reduced natural killer (NK) cell cytotoxic function i...

    Authors: Natalie Eaton-Fitch, Stanley Du Preez, Hélène Cabanas, Katsuhiko Muraki, Donald Staines and Sonya Marshall-Gradisnik
    Citation: Journal of Translational Medicine 2022 20:94
  30. Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) is characterised by severe prolonged fatigue, and decreases in cognition and other physiological functions, resulting in severe loss of quality of li...

    Authors: Ekua W Brenu, Mieke L van Driel, Don R Staines, Kevin J Ashton, Sandra B Ramos, James Keane, Nancy G Klimas and Sonya M Marshall-Gradisnik
    Citation: Journal of Translational Medicine 2011 9:81
  31. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a serious multifactorial disorder. The origin remains ambiguous, however reduced natural killer (NK) cell cytotoxicity is a consistent immunologic...

    Authors: Natalie Eaton-Fitch, Hélène Cabanas, Stanley du Preez, Donald Staines and Sonya Marshall-Gradisnik
    Citation: Journal of Translational Medicine 2021 19:306
  32. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a multi-system illness characterized, in part, by increased fatigue following minimal exertion, cognitive impairment, poor recovery to physical an...

    Authors: Betsy A Keller, John Luke Pryor and Ludovic Giloteaux
    Citation: Journal of Translational Medicine 2014 12:104
  33. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a chronic debilitating disease with huge social-economic impact. It has been suggested that immune dysregulation, nitrooxidative stress, and metab...

    Authors: Chin-An Yang, Sandra Bauer, Yu-Chen Ho, Franziska Sotzny, Jan-Gowth Chang and Carmen Scheibenbogen
    Citation: Journal of Translational Medicine 2018 16:231
  34. Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) is an etiologically unexplained disorder characterised by irregularities in various aspects of the immunological function. Presently, it is unknown w...

    Authors: Ekua W Brenu, Mieke L van Driel, Donald R Staines, Kevin J Ashton, Sharni L Hardcastle, James Keane, Lotti Tajouri, Daniel Peterson, Sandra B Ramos and Sonya M Marshall-Gradisnik
    Citation: Journal of Translational Medicine 2012 10:88
  35. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a debilitating illness. Symptoms include profound fatigue and distinctive post-exertional malaise (PEM). We asked whether a submaximal exercise te...

    Authors: Ruth R Miller, W Darlene Reid, Andre Mattman, Cristiane Yamabayashi, Theodore Steiner, Shoshana Parker, Jennifer Gardy, Patrick Tang and David M Patrick
    Citation: Journal of Translational Medicine 2015 13:159
  36. There are no known objective biomarkers to assist with the diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). A small number of studies have shown that ME/CFS patients exhibit an earlier...

    Authors: Maximillian J. Nelson, Jonathan D. Buckley, Rebecca L. Thomson, Daniel Clark, Richard Kwiatek and Kade Davison
    Citation: Journal of Translational Medicine 2019 17:80
  37. Chronic Fatigue Syndrome (CFS) is a debilitating neuro-immune disorder of unknown etiology diagnosed by an array of clinical manifestations. Although several immunological abnormalities have been described in ...

    Authors: Marta Curriu, Jorge Carrillo, Marta Massanella, Josepa Rigau, José Alegre, Jordi Puig, Ana M Garcia-Quintana, Jesus Castro-Marrero, Eugènia Negredo, Bonaventura Clotet, Cecilia Cabrera and Julià Blanco
    Citation: Journal of Translational Medicine 2013 11:68
  38. Chronic fatigue syndrome (CFS) is a long-term disabling illness accompanied by medically unexplained fatigue. This study aimed to explore the epidemiological characteristics of CFS in South Korea.

    Authors: Eun-Jin Lim, Jin-Seok Lee, Eun-Jung Lee, Seok-Ju Jeong, Ho-Young Park, Yo-Chan Ahn and Chang-Gue Son
    Citation: Journal of Translational Medicine 2021 19:502
  39. The aim of this study was to explore the tolerability and effect of static stretching (SS) and whole body cryotherapy (WBC) upon fatigue, daytime sleepiness, cognitive functioning and objective and subjective ...

    Authors: Sławomir Kujawski, Joanna Słomko, Beata R. Godlewska, Agnieszka Cudnoch-Jędrzejewska, Modra Murovska, Julia L. Newton, Łukasz Sokołowski and Paweł Zalewski
    Citation: Journal of Translational Medicine 2022 20:273
  40. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating condition characterised by fatigue and post-exertional malaise. Its pathogenesis is poorly understood. GDF15 is a circulating prote...

    Authors: A. Melvin, E. Lacerda, H. M. Dockrell, S. O’Rahilly and L. Nacul
    Citation: Journal of Translational Medicine 2019 17:409
  41. Chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME), is a severely debilitating condition of unknown etiology. The symptoms and risk factors of ME/CFS share features of accelerated agi...

    Authors: Mangalathu S. Rajeevan, Janna Murray, Lisa Oakley, Jin-Mann S. Lin and Elizabeth R. Unger
    Citation: Journal of Translational Medicine 2018 16:44
  42. Heart rate variability (HRV) is an objective, non-invasive tool to assessing autonomic dysfunction in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). People with CFS/ME tend to have lower HRV; how...

    Authors: Rosa María Escorihuela, Lluís Capdevila, Juan Ramos Castro, María Cleofé Zaragozà, Sara Maurel, José Alegre and Jesús Castro-Marrero
    Citation: Journal of Translational Medicine 2020 18:4
  43. Approximately 2.5 million people in the U.S. suffer from myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). This disease negatively impacts patients’ ability to function, often resulting in difficult...

    Authors: Turner Palombo, Andrea Campos, Suzanne D. Vernon and Shad Roundy
    Citation: Journal of Translational Medicine 2020 18:423
  44. Post-exertional malaise (PEM), the cardinal feature of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), occurs generally after exposure to a stressor. It is characterized by the worsening of ME/CFS...

    Authors: Alaa Ghali, Paul Richa, Carole Lacout, Aline Gury, Anne-Berengere Beucher, Chadi Homedan, Christian Lavigne and Geoffrey Urbanski
    Citation: Journal of Translational Medicine 2020 18:246
  45. Natural Killer (NK) cell effector functions are dependent on phosphorylation of the mitogen-activated protein kinases (MAPK) pathway to produce an effective immune response for the clearance of target cells in...

    Authors: Teilah Kathryn Huth, Donald Staines and Sonya Marshall-Gradisnik
    Citation: Journal of Translational Medicine 2016 14:97
  46. Q fever fatigue syndrome (QFS) is characterised by a state of prolonged fatigue that is seen in 20% of acute Q fever infections and has major health-related consequences. The molecular mechanisms underlying QF...

    Authors: Ruud P. H. Raijmakers, Megan E. Roerink, Anne F. M. Jansen, Stephan P. Keijmel, Ranko Gacesa, Yang Li, Leo A. B. Joosten, Jos W. M. van der Meer, Mihai G. Netea, Chantal P. Bleeker-Rovers and Cheng-Jian Xu
    Citation: Journal of Translational Medicine 2020 18:448
  47. Myalgic encephalomyelitis chronic fatigue syndrome (ME/CFS) is a common debilitating disorder associated with an intense fatigue, a reduced physical activity, and an impaired quality of life. There are no esta...

    Authors: Emmanuel Fenouillet, Aude Vigouroux, Jean Guillaume Steinberg, Alexandre Chagvardieff, Frédérique Retornaz, Regis Guieu and Yves Jammes
    Citation: Journal of Translational Medicine 2016 14:251
  48. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is hallmarked by a significant reduction in natural killer (NK) cell cytotoxicity, a mechanism tightly regulated by calcium (Ca2+). Interestingly, inter...

    Authors: Cassandra Balinas, Helene Cabanas, Donald Staines and Sonya Marshall-Gradisnik
    Citation: Journal of Translational Medicine 2019 17:401
  49. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a debilitating illness, characterised by persistent fatigue that is unrelieved by rest, in combination with a range of other disabling symptoms. T...

    Authors: Rebekah Maksoud, Cassandra Balinas, Sean Holden, Hélène Cabanas, Donald Staines and Sonya Marshall-Gradisnik
    Citation: Journal of Translational Medicine 2021 19:81

Annual Journal Metrics